Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.05.26.20113811: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding Data extraction and outcomes: Data extraction was performed based on a pre-defined data extraction form by two independent investigators (NCP, WL) blinded to each other. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Literature search: We conducted a systematic literature search of the Medline, Embase, Google Scholar, and medRxiv (the preprint server for health sciences) up to May 10, 2020 for observational studies providing any kind of association between diabetes and mortality in hospitalized patients with COVID-19. Medlinesuggested: …SciScore for 10.1101/2020.05.26.20113811: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding Data extraction and outcomes: Data extraction was performed based on a pre-defined data extraction form by two independent investigators (NCP, WL) blinded to each other. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Literature search: We conducted a systematic literature search of the Medline, Embase, Google Scholar, and medRxiv (the preprint server for health sciences) up to May 10, 2020 for observational studies providing any kind of association between diabetes and mortality in hospitalized patients with COVID-19. Medlinesuggested: (MEDLINE, RRID:SCR_002185)Embasesuggested: (EMBASE, RRID:SCR_001650)Google Scholarsuggested: (Google Scholar, RRID:SCR_008878)Risk of bias assessment: Two independent reviewers (NCP, PM) assessed the risk of bias of the included studies with Quality in Prognosis Studies tool (QUIPS) (10). Quality in Prognosissuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:The main limitation of our study is the lack of data on glucose control prior or during hospitalization. Therefore, we could not estimate the associations of controlled and uncontrolled diabetes with in-hospital mortality and we recognize that the association would probably be stronger in patients with uncontrolled diabetes and weaker in patients with controlled diabetes. A patient-level meta-analysis would be needed to assess this very important parameter. Second, the estimated association is not adjusted for other important covariates. Unfortunately, only three of the included studies provided adjusted estimates. We tried to solve this methodological issue by performing a meta-regression analysis which showed that the different rates of the other major comorbidities across different studied did not have an impact on the results. Similarly, a patient-level meta-analysis would be the ideal way to adjust for other significant covariates. Third, our meta-analysis was limited by significant heterogeneity, which we tried to assess by using a random-effects model, performing subgroups and sensitivity, and meta-regression analysis. In conclusion, the present systematic review and meta-analysis revealed that the likelihood of death is 65% higher in diabetic hospitalized patients with COVID-19 compared to non-diabetics. Further studies are needed to assess whether this association is independent or not, as well as to investigate to role of glucose control prior or during the disease....
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-